🌐 Biotech Leads 2024 VC Megadeals, Surpassing AI Biotech is outpacing AI in 2024’s VC megadeals, with 87 $100M+ rounds compared to AI’s 26. Major deals include Xaira Therapeutics’ $1 billion round and Superluminal Medicines’ $120 million, signaling strong investor confidence in health tech. 🔗 Source 🛡 Powered by V3V Ventures